Net Cash Provided by (Used in) Financing Activities of BALCHEM CORP from 31 Dec 2010 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
BALCHEM CORP annual and quarterly Net Cash Provided by (Used in) Financing Activities in USD history and change rate from 31 Dec 2010 to 31 Dec 2025.
  • BALCHEM CORP Net Cash Provided by (Used in) Financing Activities for the quarter ending 31 Mar 2025 was $31,969,000, a 6.5% decline year-over-year.
  • BALCHEM CORP annual Net Cash Provided by (Used in) Financing Activities for 2025 was $152,810,000, a 14% decline from 2024.
  • BALCHEM CORP annual Net Cash Provided by (Used in) Financing Activities for 2024 was $133,815,000, a 13% increase from 2023.
  • BALCHEM CORP annual Net Cash Provided by (Used in) Financing Activities for 2023 was $153,321,000, a 162% decline from 2022.
Source SEC data
View on sec.gov
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Change (%)

BALCHEM CORP Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $152,810,000 -$18,995,000 -14% 01 Jan 2025 31 Dec 2025 10-K 20 Feb 2026 2025 FY
2024 $133,815,000 +$19,506,000 +13% 01 Jan 2024 31 Dec 2024 10-K 20 Feb 2026 2025 FY
2023 $153,321,000 -$400,000,000 -162% 01 Jan 2023 31 Dec 2023 10-K 20 Feb 2026 2025 FY
2022 $246,679,000 +$348,857,000 01 Jan 2022 31 Dec 2022 10-K 21 Feb 2025 2024 FY
2021 $102,178,000 -$1,014,000 -1% 01 Jan 2021 31 Dec 2021 10-K 16 Feb 2024 2023 FY
2020 $101,164,000 -$144,549,000 -333% 01 Jan 2020 31 Dec 2020 10-K 24 Feb 2023 2022 FY
2019 $43,385,000 +$114,832,000 01 Jan 2019 31 Dec 2019 10-K 24 Feb 2022 2021 FY
2018 $71,447,000 -$2,821,000 -4.1% 01 Jan 2018 31 Dec 2018 10-K 19 Feb 2021 2020 FY
2017 $68,626,000 -$49,172,000 -253% 01 Jan 2017 31 Dec 2017 10-K 21 Feb 2020 2019 FY
2016 $19,454,000 +$6,388,000 +25% 01 Jan 2016 31 Dec 2016 10-K 28 Feb 2019 2018 FY
2015 $25,842,000 01 Jan 2015 31 Dec 2015 10-K 01 Mar 2018 2017 FY
2013 $16,465,000 +$26,308,000 01 Jan 2013 31 Dec 2013 10-K 27 Feb 2014 2013 FY
2012 $9,843,000 -$9,211,000 -1457% 01 Jan 2012 31 Dec 2012 10-K 27 Feb 2014 2013 FY
2011 $632,000 -$3,816,000 -120% 01 Jan 2011 31 Dec 2011 10-K 27 Feb 2014 2013 FY
2010 $3,184,000 01 Jan 2010 31 Dec 2010 10-K 25 Feb 2013 2012 FY

BALCHEM CORP Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $31,969,000 -$1,946,000 -6.5% 01 Jan 2025 31 Mar 2025 10-Q 24 Apr 2025 2025 Q1
Q1 2024 $30,023,000 +$3,295,000 +9.9% 01 Jan 2024 31 Mar 2024 10-Q 24 Apr 2025 2025 Q1
Q1 2023 $33,318,000 +$1,527,000 +4.4% 01 Jan 2023 31 Mar 2023 10-Q 03 May 2024 2024 Q1
Q1 2022 $34,845,000 -$6,912,000 -25% 01 Jan 2022 31 Mar 2022 10-Q 28 Apr 2023 2023 Q1
Q1 2021 $27,933,000 -$19,773,000 -242% 01 Jan 2021 31 Mar 2021 10-Q 29 Apr 2022 2022 Q1
Q1 2020 $8,160,000 +$23,414,000 +74% 01 Jan 2020 31 Mar 2020 10-Q 30 Apr 2021 2021 Q1
Q1 2019 $31,574,000 -$9,878,000 -46% 01 Jan 2019 31 Mar 2019 10-Q 01 May 2020 2020 Q1
Q1 2018 $21,696,000 -$1,235,000 -6% 01 Jan 2018 31 Mar 2018 10-Q 03 May 2019 2019 Q1
Q1 2017 $20,461,000 01 Jan 2017 31 Mar 2017 10-Q 04 May 2018 2018 Q1
Q1 2014 $4,962,000 -$8,434,000 -243% 01 Jan 2014 31 Mar 2014 10-Q 05 May 2014 2014 Q1
Q1 2013 $3,472,000 +$8,256,000 01 Jan 2013 31 Mar 2013 10-Q 05 May 2014 2014 Q1
Q1 2012 $4,784,000 -$1,565,000 -49% 01 Jan 2012 31 Mar 2012 10-Q 03 May 2013 2013 Q1
Q1 2011 $3,219,000 01 Jan 2011 31 Mar 2011 10-Q 10 May 2012 2012 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.